Bioorganic and Medicinal Chemistry Letters p. 2387 - 2392 (1996)
Update date:2022-09-26
Topics:
Wiley, Michael R.
Chirgadze, Nickolay Y.
Clawson, David K.
Craft, Trelia J.
Gifford-Moore, Donetta S.
Jones, Noel D.
Olkowski, Jennifer L.
Weir, Leonard C.
Smith, Gerald F.
The design, synthesis, and enzyme inhibitory profile of D-Phe-Pro-p-Amidinobenzylamine are presented. This compound has inhibitory activity equivalent to D-Phe-Pro-Arg-H, two orders of magnitude more potent than D-Phe-Pro-Agmatine. The results indicate that binding energy provided by the covalent bond of a transition-state analog can be replaced with noncovalent interactions.
View Morewebsite:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
SHENZHEN PENGCHENG REDSTAR INDUSTRY CO.,LTD
Contact:+86-755-82412922
Address:Room 8066, East Block, Square City, Jiabin Road, Luohu District
Jiaozuo Zhongwen Trading Coporation Limited
Contact:--
Address:East Renmin Road
Doi:10.1246/bcsj.54.2065
(1981)Doi:10.1016/S0968-0896(98)00152-7
(1998)Doi:10.1016/s0020-1693(97)05682-x
(1997)Doi:10.1055/s-1995-4072
(1995)Doi:10.1016/0040-4020(68)88096-2
(1968)Doi:10.1021/ja9533003
(1996)
